Recombinant Human ABCF2 Protein，His

ABCF2, a member of the ATP-binding cassette (ABC) transporter family, has garnered significant attention in recent research due to its critical role in cellular processes, including drug resistance and antigen presentation. Initially identified as an ATP-dependent protein capable of transporting various substrates, ABCF2's precise functions remain elusive, prompting extensive studies into its biological significance. The protein is particularly interesting in the context of immune responses, as it is implicated in the transport of peptides for Major Histocompatibility Complex (MHC) class I presentation, influencing the activation of CD8+ T cells. Moreover, aberrations in ABCF2 expression have been linked to several malignancies, suggesting that it may play a role in tumor biology and chemoresistance. The development of recombinant ABCF2 proteins has enabled researchers to explore its functional properties and interaction mechanisms more comprehensively, paving the way for potential therapeutic applications. By investigating the molecular dynamics and regulatory pathways associated with ABCF2, scientists aim to elucidate its role in both normal physiology and disease states, which could lead to novel strategies for overcoming drug resistance in cancer and enhancing immune responses. As such, ABCF2 not only serves as a model for understanding ABC transporter mechanisms but also represents a promising target for future therapeutic interventions.